Skip to main content
Clinical Trials

GO29665, A PHASE I/II, MULTICENTER, OPEN-LABEL, DOSE-ESCALATION STUDY OF THE SAFETY AND PHARMACOKINETICS OF COBIMETINIB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH PREVIOUSLY TREATED SOLID TUMORS

ClinicalTrials.gov Identifier

NCT02639546

For more information about this study
View Details

About This Study

To evaluate the safety, tolerability and effectiveness of cobimetinib in children and young adult patients with solid cancers, in whom prior treatment was ineffective or intolerable, or for whom no effective standard of care treatment options exist.